Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V M Brennan

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Clinical and Experimental Immunology|July 19, 2003
Prospective audit of adverse reactions occurring in 459 primary antibody-deficient patients receiving intravenous immunoglobulinV M Brennan, N J Salomé-Bentley, H M Chapel, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 1, 1997
The use of self infused intravenous immunoglobulin home therapy in the treatment of acquired chronic demyelinating neuropathiesW A Sewell, V M Brennan, M Donaghy, et al.
Journal of Clinical Immunology|March 1, 1995
Surveillance of adverse reactions in patients self-infusing intravenous immunoglobulin at homeV M Brennan, S Cochrane, C Fletcher, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Clinical and Experimental Immunology|July 19, 2003
Prospective audit of adverse reactions occurring in 459 primary antibody-deficient patients receiving intravenous immunoglobulinV M Brennan, N J Salomé-Bentley, H M Chapel, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 1, 1997
The use of self infused intravenous immunoglobulin home therapy in the treatment of acquired chronic demyelinating neuropathiesW A Sewell, V M Brennan, M Donaghy, et al.
Journal of Clinical Immunology|March 1, 1995
Surveillance of adverse reactions in patients self-infusing intravenous immunoglobulin at homeV M Brennan, S Cochrane, C Fletcher, et al.
Pageof 1